PubMed HealthSearch

PubMed · 486819

Hearing aid candidates--some relevant features.

Abstract

The age of individual seeking NHS aids has risen steadily since the service was commenced, and the median age is now over 70 years. The major type of hearing loss observed is sensorineural, but a substantial proportion of hearing aid candidates still have a significant conductive element in their hearing loss. This latter group of patients tend to be significantly younger than those without middle ear involvement. The hearing loss when applying for a hearing aid tends to be around 50 dB but is age dependent, younger subjects coming with smaller hearing losses. The most disturbing information obtained on questioning applicants was the long time lapse between recognition of hearing impairment and application for a hearing aid. This averaged almost ten years. The true delay is probably considerably greater than this and must have a substantial bearing on the outcome of hearing aid fitting. Public education and counselling of hearing aid users are suggested as vita needs.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D N Brooks. 1979. Hearing aid candidates--some relevant features.. https://doi.org/10.3109/03005367909078882

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Treatment of advanced breast cancer with norethisterone acetate.

The medical records of 84 postmenopausal women treated with oral norethisterone acetate (NTA) for advanced breast cancer were retrospectively analyzed. Treatment was devoid of significant toxicity. Twenty-one patients were not evaluable for treatment response either because of insufficient data or inadequate treatment trial. Complete plus partial response was obtained in 21 (33.3%) of the 63 evaluable patients, with a median duration of 10 months. Disease stabilization was observed in 16 (25.4%) patients for a median duration of 5 months, while 26 patients (41.3%) showed progressive disease while on treatment. The best response was observed in women with dominant soft part disease and an age over 70 (CR+PR 48%). The literature on norethisterone acetate is reviewed and compared with present results. The role of progestational agents in the treatment of advanced mammary carcinoma is discussed.

Age Factors